Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

FDA Approves New Alzheimer's Drug But Creators Biogen And Eisai Stock Slides

Forbes - 10 Jul 2023 14:00
FDA Approves New Alzheimer's Drug But Creators Biogen And Eisai Stock Slides Eisai saw its stock fall 4.67% on the news and Biogen was down 2.07%.
Full Article at Forbes

More Market News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard